About the Company
Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
Sector
Industrial Applications and Services
Industry
Laboratory Analytical Instruments
Employees
699
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PACB News
JP Morgan Downgrades Pacific Biosciences of California (PACB)
Fintel reports that on April 22, 2024, JP Morgan downgraded their outlook for Pacific Biosciences of California ...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18%
Market forces rained on the parade of Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders today, ...
Pacific Biosciences of California (PACB) Price Target Decreased by 18.15% to 9.01
The average one-year price target for Pacific Biosciences of California (NasdaqGS:PACB) has been revised to 9.01 / share.
Pacific Biosciences of California Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Pacific Biosciences of California Inc (PACB) vs. Its Peers: A Comparison
Smart investors will not be hesitating on this one! The stock price of Pacific Biosciences of California Inc (NASDAQ: PACB) has dropped by -6.21 compared to previous close of 3.38. Despite this, the ...
Pacific Biosciences of California Inc (NASDAQ: PACB) Is Up 0.60%. Can It Come Back?
Pacific Biosciences of California Inc (NASDAQ:PACB) traded at $3.35 at close of the session on Friday, April 05, made an upward move of 0.60% on its previous day’s price.
Pacific Biosciences of California, Inc.: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif., April 16, 2024 /PRNewswire/ - PacBio ...
Pacific Biosciences of California Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...